Madhya Pradesh's Global Investors Summit will bring together industry leaders, policymakers, and investors to discuss investment opportunities in textiles, manufacturing, renewable energy,...

India's amusement industry is booming, growing at 15% and expected to reach Rs 25,000 crore by 2030. Experts highlight job creation, investment opportunities, and theme park potential.

Sebi is finalizing a standard operating procedure for applying settlement regulations for cases amid rising settlement matters. The regulator is also working on uniformity in applying the...

Ukraine's Foreign Minister Andrii Sybiha will visit Mumbai on Wednesday to strengthen trade relations with India. The visit comes amid efforts to rebuild Ukraine following the Russian invasion.

INOXGFL Group plans to list INOX Clean Energy on Indian stock exchanges in FY26, aiming to raise Rs 5,000 crore through an IPO. The IPO is expected to be one of the largest in the private renewable...

Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The recalls affect Morphine Sulfate and Nelarabine Injection.

Union Minister Harsh Malhotra emphasizes the due process approach for India's digital competition law, acknowledging public feedback and best practices from other jurisdictions.

Sebi is finalizing a standard operating procedure for applying settlement regulations for cases amid rising settlement matters. The regulator is also working on uniformity in applying the...

Ukraine's Foreign Minister Andrii Sybiha will visit Mumbai on Wednesday to strengthen trade relations with India. The visit comes amid efforts to rebuild Ukraine following the Russian invasion.

INOXGFL Group plans to list INOX Clean Energy on Indian stock exchanges in FY26, aiming to raise Rs 5,000 crore through an IPO. The IPO is expected to be one of the largest in the private renewable...

Gautam Adani announces the inauguration of Navi Mumbai International Airport in June, aiming to alleviate congestion and meet growing air travel demand.

Sun Pharma and Zydus Pharmaceuticals recall products in the US due to manufacturing issues, according to the US FDA. The recalls affect Morphine Sulfate and Nelarabine Injection.